SLIDESHOW: Top 10 Cheap Blue Chip Stocks
By Dividend Channel Staff, updated Wed, May 8, 12:43 PM
This Slide: #1 of 10 |
#10. Amgen
Trading Symbol
AMGN
Recent Price
300.30
TTM Earnings
18.63
PE Ratio (TTM)
16.1
Avg Past PE (TTM)
14.8
Market Cap
161.1B
#10. Amgen
Trading Symbol
AMGN
Recent Price
300.30
TTM Earnings
18.63
PE Ratio (TTM)
16.1
Avg Past PE (TTM)
14.8
Market Cap
161.1B
Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim). More details about Amgen at: http://www.amgen.com.
ETFs holding AMGN »
Should Amgen shares be counted among the Top 10 Cheap Blue Chip Stocks? To start, we see that the recent trading price for AMGN stock is $300.30 (as of 5/7/2024). The most recent quarter's (MRQ) earnings result, annualized, was $15.84/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Amgen produced $18.63/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $19.32/share. Comparing these various earnings metrics against the stock price, we end up with a PE ratio of 15.5 for the TTM Median method, 19.0 for price to earnings using MRQ annualized, and 16.1 for current price/TTM earnings. Based on AMGN's history, that recent TTM PE is elevated relative to the historical average, with the recent PE 8.8% higher than the average (TTM method) of 14.8.
Should Amgen shares be counted among the Top 10 Cheap Blue Chip Stocks? To start, we see that the recent trading price for AMGN stock is $300.30 (as of 5/7/2024). The most recent quarter's (MRQ) earnings result, annualized, was $15.84/share. Looking at the sum total of quarterly earnings across the trailing twelve month (TTM) period, Amgen produced $18.63/share. And taking the median quarterly result across the TTM period, and annualizing it, results in $19.32/share. Comparing these various earnings metrics against the stock price, we end up with a PE ratio of 15.5 for the TTM Median method, 19.0 for price to earnings using MRQ annualized, and 16.1 for current price/TTM earnings. Based on AMGN's history, that recent TTM PE is elevated relative to the historical average, with the recent PE 8.8% higher than the average (TTM method) of 14.8.
AMGN Next Dividend Date » (Projection based upon history) AMGN Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (2.84 out of 4) 26th percentile
(ranked lower than approx. 74% of all stocks covered)
Analysts' Target Price: AMGN Forecast Based on data provided by Zacks Investment Research via Quandl.com |
|